Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Tatarov

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Cancer Drug Targets|June 29, 2010
Is Src a viable target for treating solid tumours?B Elsberger, B Stewart, O Tatarov, et al.
Scottish Medical Journal|November 10, 2012
Sacral nerve stimulation for urinary dysfunction: the first year of the Scottish national serviceM Hilmy, O Tatarov, L McQueen, et al.
British Journal of Cancer|November 20, 2008
Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancerE J Campbell, E McDuff, O Tatarov, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Cancer Drug Targets|June 29, 2010
Is Src a viable target for treating solid tumours?B Elsberger, B Stewart, O Tatarov, et al.
Scottish Medical Journal|November 10, 2012
Sacral nerve stimulation for urinary dysfunction: the first year of the Scottish national serviceM Hilmy, O Tatarov, L McQueen, et al.
British Journal of Cancer|November 20, 2008
Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancerE J Campbell, E McDuff, O Tatarov, et al.
Pageof 1